{"mainPropery":{"diseaseId":8472,"diseaseName":"Muckle-Wells syndrome","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/8472/muckle-wells-syndrome","synonyms":["Urticaria, deafness and amyloidosis","Urticaria-deafness-amyloidosis syndrome","UDA syndrome","Muckle Wells syndrome"],"synonyms-with-source":[{"name":"Urticaria, deafness and amyloidosis"},{"name":"Urticaria-deafness-amyloidosis syndrome"},{"name":"UDA syndrome"},{"name":"Muckle Wells syndrome"}],"identifiers":[{"identifierType":"OMIM","identifierId":"191900"},{"identifierType":"ORPHANET","identifierId":"575"},{"identifierType":"UMLS","identifierId":"C0268390"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":13,"diseaseTypeName":"Immune System Diseases","source":"Orphanet"},{"diseaseTypeId":26,"diseaseTypeName":"Kidney and Urinary Diseases","source":"Orphanet"},{"diseaseTypeId":15,"diseaseTypeName":"Musculoskeletal Diseases","source":"Orphanet"},{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":3600,"resourceName":"FMF & AID Global Association","abbreviation":"","address1":"Schüracherstrasse 25a","address2":"8306 Brüttisellen","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"Switzerland","phone":"+41 76 415 4010","tty":"","tollFree":"","fax":"","email":"info@fmfandaid.org ","url":"https://www.fmfandaid.org/","freeText":""},{"resourceID":4018,"resourceName":"Primary Immune Deficiency UK","abbreviation":"PID UK","address1":"PO Box 6970","address2":"","address3":"","address4":"","address5":"","city":"Basingstoke","state":"","zip":"RG24 4XL","country":"United Kingdom","phone":"","tty":"","tollFree":"0800 987 8986","fax":"","email":"hello@piduk.org","url":"http://www.piduk.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/191900' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=%28Muckle%2DWells%5BAll+Fields%5D+AND+%28%22syndrome%22%5BMeSH+Terms%5D+OR+%22syndrome%22%5BAll+Fields%5D%29%29+AND+hasabstract%5Btext%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Muckle-Wells syndrome. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Muckle-Wells+syndrome%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Muckle-Wells syndrome. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=mucklewellssyndrome' target='_blank'>MedlinePlus Genetics</a> contains information on Muckle-Wells syndrome. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":336,"resourceId":1154,"resourceName":"RareConnect","descriptionText":"<div style=\"margin-top: 0px; margin-bottom: 0px;\"><a href='https://www.rareconnect.org/en/community/caps' target='_blank'>RareConnect</a> has an online community for patients&nbsp;and families with this condition so they can connect with others and share&nbsp;their experiences living with a rare disease.&nbsp;The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders).</div>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":720,"resourceId":1415,"resourceName":"Cryopyrin-Associated Periodic Syndromes_ full text article","descriptionText":"Leigh D Church, Sinisa Savic, and Michael F McDermott; <em><a href='http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=19707454 ' target='_blank'>Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap), </a></em>Biologics. <span class=\"citation-publication-date\">2008 December; </span><span class=\"citation-volume\">2</span><span class=\"citation-issue\">(4)</span><span class=\"citation-flpages\">: 733–742.</span>","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":1158,"resourceId":1838,"resourceName":"Muckle-Wells syndrome - FDA","descriptionText":"<a href='http://www.fda.gov/bbs/topics/NEWS/2008/NEW01801.html ' target='_blank'>The United States Food and Drug Administration</a> approved a new drug for the treatment of rare inflammatory syndromes, including Muckle-Wells syndrome, in February of 2008. More information about Muckle-Wells syndrome and this treatment can be found by clicking on the above link.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1254,"resourceId":1919,"resourceName":"Cleveland Clinic-Periodic Fever Syndrome","descriptionText":"<a href='https://my.clevelandclinic.org/health/articles/17354-periodic-fever-syndrome' target='_blank'>The Cleveland Clinic</a> provides an overview of the different types of periodic fever syndromes.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1191/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/952254-overview#aw2aab6b6' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=575' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1550,"resourceId":2178,"resourceName":"DermNet New Zealand","descriptionText":"<a href='http://dermnetnz.org/systemic/muckle-wells.html' target='_blank'>DermNet NZ</a> is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:191900' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":1826,"questionText":"What is Muckle-Wells syndrome?","answerText":"<strong>Muckle-Wells syndrome</strong>&nbsp;is an <a href=\"http://www.niams.nih.gov/Health_Info/Autoinflammatory/default.asp\" target=\"_blank\">autoinflammatory disease</a>, and the intermediate form of <a href=\"http://dermnetnz.org/systemic/caps.html\" target=\"_blank\">cryopyrin-associated periodic syndrome</a> (CAPS). Signs and symptoms may include recurrent episodes of fever, skin rash, joint pain, abdominal pain, and&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/pinkeye.html\" target=\"_blank\">pinkeye</a>;&nbsp;progressive <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003291.htm\" target=\"_blank\">sensorineural deafness</a>;&nbsp;and <a href=\"http://www.nlm.nih.gov/medlineplus/amyloidosis.html\" target=\"_blank\">amyloidosis</a>. It is caused by mutations in the <em><a href=\"http://ghr.nlm.nih.gov/gene/NLRP3\" target=\"_blank\">NLRP3</a></em> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner. Treatment includes medications such as canakinumab and rilonacept.[7328]","dateModified":"2014-04-07T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":12739,"relatedDiseaseName":"Secondary glomerular disease","relation":"Parent","isRare":true,"hasGardPage":false}],"gardCases":[{"caseId":44872,"abbreviatedInquiry":"Is there a written language expressive disorder, or component, noted with Muckle Wells syndrome?  It would be helpful to know if there are any educational learning disabilities associated with this syndrome other than potential for hearing loss and related concerns with hearing loss.","caseQuestions":[{"questionId":7430,"questionText":"Do people with Muckle-Wells syndrome have learning disabilities?","answerText":"Learning disabilities, including expressive language disorders, are generally not reported as a feature of Muckle-Wells syndrome. <br />\r\n<br />\r\nThe gene responsible for Muckle-Wells syndrome, called&nbsp;<em><a href=\"http://ghr.nlm.nih.gov/gene/NLRP3\" target=\"_blank\">NLRP3</a>,</em> is also responsible for related conditions including the less severe <a href=\"http://rarediseases.info.nih.gov/gard/9535/familial-cold-autoinflammatory-syndrome/resources/1\" target=\"_blank\">familial cold autoinflammatory syndrome</a> and the more severe <a href=\"http://rarediseases.info.nih.gov/gard/1356/chronic-infantile-neurological-cutaneous-articular-syndrome/resources/1\" target=\"_blank\">neonatal onset multisystem inflammatory disease</a> (also called NOMID, or CINCA). These conditions are collectively called cryopyrin associated periodic syndromes (CAPS). Some authors have suggested that the signs and symptoms of people with <em>NLRP3</em> gene mutations may overlap more than previously thought.[7332] The features that typically distinguish NOMID from the other conditions include chronic aseptic\r\nmeningitis, which can result in severe developmental delay and disability.[7333] While people diagnosed with Muckle-Wells syndrome generally do not have chronic aseptic meningitis, mild features of NOMID have been reported in some people with Muckle-Wells syndrome.[7333]","dateModified":"2014-04-08T00:00:00","references":[{"referenceId":7332,"authors":"Philip N. Hawkins, Helen J. Lachmann, Ebun Aganna, and Michael F. McDermott","articleTitle":"Spectrum of Clinical Features in Muckle-Wells Syndrome and Response to Anakinra","bookWebsiteJournalTitle":"ARTHRITIS & RHEUMATISM","date":"February, 2004","volume":"50(2)","pages":"607-612","url":"","dateAccessed":"2014-04-08T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7333,"authors":"Delwyn Dyall-Smith","articleTitle":"NOMID/CINCA syndrome","bookWebsiteJournalTitle":"DermNet NZ","date":"December 29, 2013","volume":"","pages":"","url":"http://dermnetnz.org/systemic/nomid-cinca.html","dateAccessed":"2014-04-08T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":32537,"abbreviatedInquiry":"Is Muckle-Wells Syndrome life threatening?","caseQuestions":[{"questionId":5446,"questionText":"Is Muckle-Wells Syndrome life threatening?","answerText":"Muckle-Wells syndrome can have severe&nbsp;consequences as a result of long-term high levels of inflammation in the body.[4498]&nbsp;In some patients, this leads to secondary or <a href=\"http://www.amyloidosis.org/TreatmentInformation/secondaryAA.html\">AA amyloidosis</a>,&nbsp;an abnormal accumulation of&nbsp;the protein amyloid in the tissues and organs.&nbsp;This can become life-threatening due to a permanent build-up of amyloid in the kidneys, liver, spleen, and elsewhere.[4498][4499]&nbsp;The most common clinical presentation is <a href=\"http://www.nlm.nih.gov/medlineplus/kidneyfailure.html\" target=_blank>kidney failure</a>.[4499]&nbsp;","dateModified":"2011-10-17T16:59:00","references":[{"referenceId":4498,"authors":"","articleTitle":"Muckle-Wells Syndrome (MWS) ","bookWebsiteJournalTitle":"NOMID Alliance","date":"","url":"http://www.nomidalliance.net/subpage.html","dateAccessed":"2011-10-17T00:00:00"},{"referenceId":4499,"authors":"","articleTitle":"Secondary AA","bookWebsiteJournalTitle":"Amyloidosis Foundation","date":"","url":"http://www.amyloidosis.org/TreatmentInformation/secondaryAA.html","dateAccessed":"2011-10-17T00:00:00"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":7919,"phenoTypeName":"Arthralgia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5670,"phenoTypeName":"Arthritis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3898,"phenoTypeName":"Broad foot","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5616,"phenoTypeName":"Conjunctivitis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":12141,"phenoTypeName":"Cranial nerve paralysis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11716,"phenoTypeName":"Episcleritis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11338,"phenoTypeName":"Progressive sensorineural hearing impairment","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8270,"phenoTypeName":"Skin rash","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9144,"phenoTypeName":"Uveitis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13419,"phenoTypeName":"Abdominal pain","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6246,"phenoTypeName":"Elevated erythrocyte sedimentation rate","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10043,"phenoTypeName":"Nephropathy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6347,"phenoTypeName":"Nephrotic syndrome","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15555,"phenoTypeName":"Renal amyloidosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8303,"phenoTypeName":"Urticaria","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9772,"phenoTypeName":"Abnormal palate morphology","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10012,"phenoTypeName":"Abnormality of the genital system","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11304,"phenoTypeName":"Abnormality of the nose","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4765,"phenoTypeName":"Abnormality of the voice","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15539,"phenoTypeName":"Anemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11669,"phenoTypeName":"Camptodactyly of finger","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6028,"phenoTypeName":"Delayed puberty","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13043,"phenoTypeName":"Fever","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5610,"phenoTypeName":"Glaucoma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3586,"phenoTypeName":"Hernia of the abdominal wall","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14464,"phenoTypeName":"Ichthyosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9851,"phenoTypeName":"Macrocephaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3980,"phenoTypeName":"Myalgia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10124,"phenoTypeName":"Optic atrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3896,"phenoTypeName":"Pes cavus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":317,"phenoTypeName":"Recurrent aphthous stomatitis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13724,"phenoTypeName":"Restrictive ventilatory defect","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3605,"phenoTypeName":"Short stature","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13800,"phenoTypeName":"Vasculitis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9746,"phenoTypeName":"Abnormality of the mouth","percentRanges":"-"},{"phenoTypeId":10274,"phenoTypeName":"Abnormality of the skin","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":11303,"phenoTypeName":"Hearing impairment","percentRanges":"-"},{"phenoTypeId":6245,"phenoTypeName":"Infantile onset","percentRanges":"-"},{"phenoTypeId":13075,"phenoTypeName":"Leukocytosis","percentRanges":"-"},{"phenoTypeId":13054,"phenoTypeName":"Recurrent fever","percentRanges":"-"},{"phenoTypeId":10015,"phenoTypeName":"Renal insufficiency","percentRanges":"-"}],"medicalProducts":[{"productId":404,"genericName":"Rilonacept","tradeName":"Arcalyst","tradeLink":"https://www.arcalyst.com/","manufacturer":"","sponsor":"Regeneron Pharmaceuticals, Inc.","indication":"February 2008, rilonacept (Arcalyst) was approved for treatment of cryopyrin-assisted periodic syndromes (CAPS).","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/arcalyst","medlinePlusLink":""},{"productId":499,"genericName":"Canakinumab","tradeName":"Ilaris","tradeLink":"http://ilaris.com/index.jsp","manufacturer":"","sponsor":"Novartis Pharmaceuticals Corporation","indication":"June 2009, canakinumab (Ilaris) was approved for the treatment of cryopyrin-associated periodic syndromes (CAPS), in adults and children 4 years of age and older. In May 2013, it was also approved for the treatment of active Systemic Juvenile Idiopathic Arthritis (SJIA) in patients aged 2 through 16 years.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/ilaris","medlinePlusLink":""}],"EncodedName":"Muckle-Wells_syndrome"}